Production and uses of artifical histone h1 for analyzing, diagnosing, treating, and/or preventing senescence
OwnerFelipe Velosoinventor
Life of this patent
Estimating the term…
Loading patent…
OwnerFelipe Velosoinventor
Estimating the term…
The present invention provides a method for producing artificial protein sequences and artificial nucleic acid sequences for the linker histone variants H1.0 (also known as histone H1°; H1(0); H5; H1δ; RI H1; or H1 histone family, member 0) and H1x (also known as histone H1.10 or H1 histone family, member X). In particular, the artificial protein sequences produced by the method feature engineered α-helical motifs—three structural motifs in the histone H1 that bind to nucleosomal and/or linker DNA in chromatin. These artificial-sequence histone H1 proteins, when they replace or supplement their wild-type counterparts in vivo, confer multicellular individuals significant resistance to senescence and/or age-related health conditions such as age-related cancer.
A method for producing an artificial protein sequence for histone H1 variants to induce resistance and/or protection against senescence, and/or age-related health conditions wherein the method comprises the steps of:
An artificial histone H1.0 or H1x protein sequence for inducing resistance and/or protection against senescence, and/or age-related health conditions wherein the artificial protein sequence contains a set of at least one amino acid substitutions, insertions, and/or deletions to the DNA-binding site of the histone H1.0 or H1x proteins in the α-helical regions, where the substitutions, insertions, and/or deletions do not alter the structure of the α-helices and entail an increase in the net electric charge (z), particularly at physiological pH, of the resulting artificial-sequence protein.
Dependencies are inferred from the claim text.